Packard C J, Gaw A, Demant T, Shepherd J
Institute of Biochemistry, Glasgow Royal Infirmary, UK.
J Lipid Res. 1995 Jan;36(1):172-87.
A multicompartmental model has been devised to explain apolipoprotein B (apoB) kinetics in very low density lipoprotein subfractions (VLDL1 Sf 60-400 and VLDL2 Sf 20-60), intermediate density (IDL Sf 12-20) and low density lipoproteins (LDL Sf 0-12). Normal and hyperlipemic subjects were given tracer doses of 131I-labeled VLDL1 and 125I-labeled VLDL2 and the metabolism of apoB in VLDL1, VLDL2, IDL, and LDL was followed over a period of 13 days. VLDL1 apoB and VLDL2 apoB clearance curves had an initial shoulder, a rapid decay, and a 'tail' of slowly metabolized lipoprotein. ApoB derived from VLDL1 appeared in IDL over 10-50 h and exhibited bi-exponential decay that was attributed to the presence of two metabolically distinct species. A further compartment was required to explain the observation that a substantial proportion of apoB from VLDL2 appeared and disappeared from the IDL density range faster than apoB derived from VLDL1 delipidation. Both of the more rapidly removed IDL species gave rise to LDL apoB that was also modeled as a heterogeneous entity with two plasma compartments. The final model, which has much in common with previous versions (M. Berman et al. 1978. J. Lipid Res. 19: 38-56), a multi-step delipidation pathway and slowly metabolized remnant compartments in VLDL, incorporates parallel delipidation routes in VLDL2, IDL, and LDL. These parallel pathways linked kinetic heterogeneity in VLDL with that in IDL and LDL.
已设计出一种多室模型来解释极低密度脂蛋白亚组分(VLDL1 Sf 60 - 400和VLDL2 Sf 20 - 60)、中间密度脂蛋白(IDL Sf 12 - 20)和低密度脂蛋白(LDL Sf 0 - 12)中载脂蛋白B(apoB)的动力学。给正常和高脂血症受试者注射示踪剂量的131I标记的VLDL1和125I标记的VLDL2,并在13天内追踪VLDL1、VLDL2、IDL和LDL中apoB的代谢情况。VLDL1 apoB和VLDL2 apoB清除曲线有一个初始平台期、快速衰减期以及缓慢代谢脂蛋白的“尾巴”。源自VLDL1的apoB在10 - 50小时内出现在IDL中,并呈现双指数衰减,这归因于存在两种代谢不同的物质。需要另一个室来解释以下观察结果:来自VLDL2的apoB相当一部分在IDL密度范围内出现和消失的速度比源自VLDL1脱脂的apoB更快。两种去除更快的IDL物质都产生了LDL apoB,其也被建模为具有两个血浆室的异质实体。最终模型与先前版本(M. Berman等人,1978年。《脂质研究杂志》19:38 - 56)有很多共同之处,它具有多步骤脱脂途径以及VLDL中缓慢代谢的残余室,在VLDL2、IDL和LDL中纳入了平行的脱脂途径。这些平行途径将VLDL中的动力学异质性与IDL和LDL中的动力学异质性联系起来。